Quotient Limited's ability to collect accounts receivable sequentially worsen to 6.27, pointing to a challenging and on top of that deteriorating business climate for the In Vitro & In Vivo Diagnostic Substances industry. Quotient Limited's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 58 days, from 55 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 317 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2022 from 1888 to 1889.

What is Receivable Turnover Ratio?
What is Quotient Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

QTNT Receivables Turnover Ratio	(Dec 31 2022) III. Quarter	(Sep 30 2022) II. Quarter	(Jun 30 2022) I. Quarter	(Mar 31 2022) IV. Quarter	(Dec 31 2021) III. Quarter
Y / Y Receivable Change	8.15 %	3.54 %	13.57 %	17.83 %	35.4 %
Y / Y Revenue Change	-11.03 %	-7.69 %	-4.35 %	1.54 %	16.24 %
Receivable Turnover Ratio (TTM)	6.27	6.6	6.78	7.04	7.34
QTNT's Total Ranking	# 1889	# 1888	# 3097	# 3097	#
Accounts Receivable average collection period days	58	55	54	52	50
Seq. Receivable Change	28.39 %	2.39 %	-19.39 %	2.05 %	22.92 %
Seq. Revenue Change	3.56 %	0.52 %	-11.16 %	-3.79 %	7.45 %

Receivable Turnover Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 12
Healthcare Sector	# 318
Overall Market	# 1889

Receivable Turnover Ratio Statistics
High	Average	Low
10.51	8.52	6.41
(Mar 31 2019)		(Dec 31 2022)

QTNT Company Profile • Back to QTNT Efficiency Comparisons • Compare QTNT Receivables Turnover Ratio to its Competitors

Financial Statements
Quotient Limited's Accounts Receivable	$ 7 Millions	Visit QTNT's Balance sheet
Quotient Limited's Sales TTM	$ 36 Millions	Visit QTNT's Income Statement
Sources of QTNT's Revenues		Visit QTNT's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
QTNT's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
QTNT's Growth Rates	QTNT's Roa	QTNT's Inventory Turnover Ratio	QTNT's Dividend Comparisons
QTNT's Profitability Ratios	QTNT's Roi	QTNT's Asset Turnover Ratio	QTNT's Dividend Growth
QTNT's Valuation Ratios	QTNT's Roe	QTNT's Financial Strength Ratios	QTNT's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2022	Receivable at quarter ending Dec 31 2022
Adagene Inc	15.00	$ 9.293 Millions	$ 0.619 Millions
Sigilon Therapeutics Inc	14.52	$ 12.944 Millions	$ 0.892 Millions
Kiniksa Pharmaceuticals International Plc	14.42	$ 220.180 Millions	$ 15.267 Millions
Theralink Technologies Inc	14.36	$ 0.544 Millions	$ 0.038 Millions
23andme Holding Co	14.31	$ 307.671 Millions	$ 21.498 Millions
Travere Therapeutics Inc	13.98	$ 212.018 Millions	$ 15.170 Millions
Corcept Therapeutics Inc	13.88	$ 401.858 Millions	$ 28.953 Millions
Harrow Inc	13.77	$ 88.595 Millions	$ 6.436 Millions
Immutep Limited	13.63	$ 6.758 Millions	$ 0.496 Millions
Burning Rock Biotech Limited	13.51	$ 81.662 Millions	$ 6.044 Millions
Lipocine Inc	13.25	$ 1.066 Millions	$ 0.080 Millions
Cano Health Inc	13.22	$ 2,738.916 Millions	$ 207.142 Millions
Neurometrix Inc	12.80	$ 8.256 Millions	$ 0.645 Millions
Invo Fertility Inc	12.47	$ 0.822 Millions	$ 0.066 Millions
Tango Therapeutics Inc	12.43	$ 24.860 Millions	$ 2.000 Millions
Agenus Inc	12.31	$ 98.024 Millions	$ 7.961 Millions
Semler Scientific inc	12.25	$ 56.686 Millions	$ 4.629 Millions
Lifeloc Technologies Inc	12.03	$ 8.482 Millions	$ 0.705 Millions
Avita Medical Inc	11.96	$ 34.421 Millions	$ 2.879 Millions
International Stem Cell Corporation	11.95	$ 8.180 Millions	$ 0.685 Millions
Teladoc Health Inc	11.90	$ 2,406.840 Millions	$ 202.304 Millions
Ngm Biopharmaceuticals Inc	11.81	$ 55.333 Millions	$ 4.684 Millions
Morphosys Ag	11.47	$ 311.659 Millions	$ 27.163 Millions
Myovant Sciences Ltd	11.43	$ 379.112 Millions	$ 33.176 Millions
Scienture Holdings Inc	11.41	$ 10.451 Millions	$ 0.916 Millions
Tg Therapeutics Inc	11.24	$ 2.785 Millions	$ 0.248 Millions
Legend Biotech Corporation	11.20	$ 117.005 Millions	$ 10.444 Millions
Exact Sciences Corporation	11.20	$ 2,070.489 Millions	$ 184.854 Millions
Cue Health Inc	11.15	$ 483.476 Millions	$ 43.342 Millions
Embecta Corp	11.14	$ 1,115.900 Millions	$ 100.150 Millions

Date modified: 2026-09-08T15:22:10+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.